← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2018Last known activity
Apr 9, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (12 distinct, 5 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT06265051CollaboratorPhase 2/Phase 3Apr 9, 2024
- NCT04982380CollaboratorPhase 4Jul 31, 2021
- NCT04813445CollaboratorN/AMar 28, 2021
- NCT04400695Overall official - principal investigatorPhase 3Jul 31, 2020
- NCT03733002CollaboratorPhase 3Dec 1, 2018
Details
- Last known activity
- Apr 9, 2024